Our mission is opening a digital front door to a new kind of healthcare system, one that provides greater access to high quality, convenient and affordable care. No matter who a person is, where they come from, what they look like, or if they have insurance or not—Hims & Hers connects consumers with licensed medical professionals and enables everyone to seek health and wellness care.

HIMS

Andrew Dudum

Chief Executive Officer

Melissa Baird

Chief Operating Officer

Soleil Boughton

Chief Legal Officer and Corporate Secretary

Yemi Okupe

Chief Financial Officer

Chief Executive Officer And Board Of Director

Alex Bard

Board Of Director

Dr. Toby Cosgrove

M.D. Board Of Director

Kirsten Green

Jules Maltz

David Wells

Lynne Chou O’keefe

Andrea Perez

Ambar Bhattacharyya

Dr. Patrick Carroll

About HIMS

Hims & Hers Health Option Alert: Apr 4 $35 Calls Sweep (3) near the Bid: 1854 vs 4834 OI; Earnings 5/5 After Close [est] 

Hims & Hers Health Option Alert: Apr 4 $35 Calls Sweep (3) near the Bid: 1854 @ $3.951 vs 4834 OI; Earnings 5/5 After Close [est] Ref=$37.43

Hims & Hers Health

HIMS & HERS HEALTH INC

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.

Hims & Hers Health, Inc. Class A Common Stock

VKTX


When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off-label use by celebrities and social media influencers for cutting weight became a viral

Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?

Screenshot 2025-03-12 at 6.12.59 PM

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Emerging Markets

Markets

TSLA

LikeFolio&#39;s Top 7 Stock Picks (And One Crypto) For This Market Pullback


Novo Nordisk A/S (NYSE:NVO) has declared that its GLP-1 drugs for chronic obesity, under the brands Ozempic and Wegovy, are no longer in short supply. This caused the United States Food and Drug Administration (FDA) to

Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors

Hims & Hers Health Inc

Press Releases

Hims & Hers Named to Inc.'s 2024 Best in Business List in Health Products Category

The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight

Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025

Hims & Hers Launches Health Collective and Community Member Council

Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers

Hims & Hers Acquires US-based Peptide Facility

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Mutual Funds

DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

Define Ventures Appoints Carolyn Magill as Venture Partner

Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers

AMBC

BBWI

CLSK

DASH

FLGT

FRPT

GDOT

GPRE

HAIN

ISRG

KTOS

LVGO

MATV

NEOG

PLTR

RKLB

SATS

SPGI

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

Amedisys

AMN Healthcare Services

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna Group

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Fresenius Medical Care

Guardant Health

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Gr

Labcorp Hldgs

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

NeoGenomics

Option Care Health

OPKO Health

Premier

Privia Health Gr

RadNet

GeneDx Holdings Corp. - Class A Common Stock

GeneDx Holdings

B of A Securities

Citigroup

Truist Securities

Leerink Partners

Piper Sandler

Screenshot 2024-09-04 at 5.36.44 PM

Biotech

General

MGRX

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

Screenshot 2024-07-09 at 1.59.17 PM

Health Care

Erectile Function Vs Erectile Dysfunction: How MangoRx&#39;s (NASDAQ: MGRX) Product Sets Itself Apart And Caters To A Large Market (Pun Intended)

Comments

Hims & Hers Health

Unusual Options Activity for

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga